Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen-Reference-Cited by-同舟云学术

Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen

Published:2015-09-30 Issue:4 Volume:65 Page:658-671
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Zhang Tian-Ying,Yuan Quan,Zhao Jing-Hua,Zhang Ya-Li,Yuan Lun-Zhi,Lan Ying,Lo Yu-Chieh,Sun Cheng-Pu,Wu Chang-Ru,Zhang Jun-Fang,Zhang Ying,Cao Jia-Li,Guo Xue-Ran,Liu Xuan,Mo Xiao-Bing,Luo Wen-Xin,Cheng Tong,Chen Yi-Xin,Tao Mi-Hua,Shih James WK,Zhao Qin-Jian,Zhang Jun,Chen Pei-Jer,Yuan Y Adam,Xia Ning-Shao

Publisher

BMJ

Subject

Gastroenterology

Reference33 articles.

1. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

2. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group;Chang;N Engl J Med,1997

3. Hepatitis B virus infection;Liaw;Lancet,2009

4. Emerging drugs for hepatitis B;Zoulim;Expert Opin Emerg Drugs,2007

5. The growth and potential of human antiviral monoclonal antibody therapeutics;Marasco;Nat Biotechnol,2007

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control;Antiviral Research;2024-10

2. HBsAg and TLR7/8 dual-targeting antibody-drug conjugates induce sustained anti-HBV activity in AAV/HBV mice: a preliminary study;Antibody Therapeutics;2024-07

3. Investigation of hepatitis B virus mutations associated with immune escape and drug resistance in human immunodeficiency virus-infected patients;F1000Research;2024-05-30

4. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels;Journal of Hepatology;2024-05

5. Preclinical animal models to evaluate therapeutic antiviral antibodies;Antiviral Research;2024-05